Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check28 days agoChange DetectedThe website has updated its list of principal investigators, removing previous entries and adding new ones, while also changing the version from v2.13.3 to v2.14.0.SummaryDifference49%
- Check35 days agoNo Change Detected
- Check49 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check57 days agoChange DetectedThe website has been updated from version 2.13.0 to 2.13.2, indicating new features or improvements.SummaryDifference0.0%
- Check64 days agoChange DetectedThe website has updated the contact details section for the study, now providing clearer information on who to contact for questions and where the study is taking place, reflecting a revision from v2.12.2 to v2.13.0.SummaryDifference1%
- Check71 days agoChange DetectedSeveral key resources related to idiopathic pulmonary fibrosis and other genetic conditions have been removed from the website, including links to MedlinePlus and NIH, which may impact access to important health information.SummaryDifference2%
Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.